Trademark Overview
On Monday, November 17, 2025, a trademark application was filed for HALOZYME HYPERCON with the United States Patent and Trademark Office. The USPTO has given the HALOZYME HYPERCON trademark a serial number of 99501527. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, November 17, 2025. This trademark is owned by Halozyme, Inc.. The HALOZYME HYPERCON trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:
Research and development in the field of pharmaceuticals and drug delivery; scientific and medical research, namely, conducting clinical trials for others; Scientific research and design and development, namely, product design and development in the field of excipients and formulations for use with therapeutic biologics; Scientific research and design, namely product design and development in the field of therapeutic formulation development; Consulting in the fields of product design and development in the field of therapeutic formulation and excipient development; Chemical engineering in the nature of formulation and reformulation of therapeutic compositions; Development of new technology for others in the field of biomaterials, biotechnology and nanotechnology
Custom manufacture of reformulated pharmaceuticals for easier patient delivery; Custom manufacturing, processing, and treating the therapeutic molecules of others; Biomanufacturing for others, namely, manufacturing therapeutic molecules of others using biological organisms in the manufacturing process; Custom manufacture of reformulated pharmaceuticals and therapeutics
